RPG Life Sciences posts Q3 FY25 PAT higher at Rs. 34.93 Cr

RPG Life Sciences posts Q3 FY25 PAT higher at Rs. 34.93 Cr

By: IPP Bureau

Last updated : January 28, 2025 9:31 am



RPG Life Sciences has reported total income of Rs. 176.02 crore during the period ended December 31, 2024


RPG Life Sciences Limited has reported standalone financial results for the period ended December 31, 2024.

RPG Life Sciences has posted net profit of Rs. 34.93 crore for the period ended December 31, 2024 as against net profit of Rs. 4.20 crore for the period ended September 30, 2024. The company posted net profit of Rs. 26.46 crores for the period ended December 31, 2023.

RPG Life Sciences has reported total income of Rs. 176.02 crore during the period ended December 31, 2024 as compared to Rs. 174.15 crore during the period ended September 30, 2024. The company reported total income of Rs.155.62 crores during the period ended December 31, 2023.

For the 9 months period ended December 31, 2024, the company has reported total income of Rs. 517.96 crore as compared to Rs.460.62 crores during the 9 months period ended December 31, 2023.

The company has posted net profit of Rs. 65.89 crore for the 9 months period ended December 31, 2024 as against net profit of Rs. 74.42 crore for the 9 months period ended December 31, 2023.

RPG Life Sciences Limited

First Published : January 28, 2025 12:00 am